0
Skip to Content
Health Business Group
Services ▾
Growth Strategy
Due Diligence for Transactions
Sectors ▾
Tech-enabled Healthcare Services
Life Sciences
Digital Health and Health IT
Private Equity/Investors
About ▾
Consultants
Case Studies
History
Testimonials
Media Room
blog
Contact
Health Business Group
Services ▾
Growth Strategy
Due Diligence for Transactions
Sectors ▾
Tech-enabled Healthcare Services
Life Sciences
Digital Health and Health IT
Private Equity/Investors
About ▾
Consultants
Case Studies
History
Testimonials
Media Room
blog
Contact
Folder: Services ▾
Back
Growth Strategy
Due Diligence for Transactions
Folder: Sectors ▾
Back
Tech-enabled Healthcare Services
Life Sciences
Digital Health and Health IT
Private Equity/Investors
Folder: About ▾
Back
Consultants
Case Studies
History
Testimonials
Media Room
blog
Contact
Patients, Pharma, Podcast, Technology 8/12/19 Patients, Pharma, Podcast, Technology 8/12/19

Life Image CTO Janak Joshi discusses real world evidence (RWE) --podcast

Read More
Economics, Pharma, Policy and politics 6/20/19 Economics, Pharma, Policy and politics 6/20/19

Should ICER be NICER? The case for analyzing the value of drugs

Read More
Pharma, Podcast 2/25/19 Pharma, Podcast 2/25/19

Agenus plans digital security offering. PCG's Jeff Ramson explains in this podcast

Read More
Pharma, Policy and politics 4/17/18 Pharma, Policy and politics 4/17/18

Ten pharma policy topics in just one article!

Read More
Devices, Entrepreneurs, Pharma, Podcast 3/26/18 Devices, Entrepreneurs, Pharma, Podcast 3/26/18

Reducing variance in medical device and drug utilization. Podcast with Lumere CEO Hani Elias

Read More
Pharma, Technology 10/31/17 Pharma, Technology 10/31/17

How formidable would Amazon be in pharmacy?

Read More
Culture, Patients, Pharma 8/29/17 Culture, Patients, Pharma 8/29/17

Hospice: Another sad sector of the opioid crisis

Read More
Pharma, Podcast 3/20/17 Pharma, Podcast 3/20/17

Drug treatment for opioid addiction: Podcast interview with CleanSlate CEO Greg Marotta

Read More
Devices, Pharma, Technology 3/6/17 Devices, Pharma, Technology 3/6/17

eCOA in action: Podcast interview with iCardiac CEO, Alex Zapesochny

Read More
Pharma, Policy and politics, Uncategorized 2/1/17 Pharma, Policy and politics, Uncategorized 2/1/17

What if the FDA is eliminated?

Read More
Pharma, Research 12/15/16 Pharma, Research 12/15/16

Just a granule of sugar makes the medicine go down (and out)

Read More
Pharma, Policy and politics 12/9/16 Pharma, Policy and politics 12/9/16

Would an FDA radical make any real difference?

Read More
Entrepreneurs, Pharma, Podcast, Policy and politics 11/28/16 Entrepreneurs, Pharma, Podcast, Policy and politics 11/28/16

Recreational marijuana is becoming legal. How will the laws be implemented?

Read More
Economics, Pharma, Policy and politics 11/1/16 Economics, Pharma, Policy and politics 11/1/16

PCSK9 experience shows drug market isn't completely broken

Read More
Devices, Economics, Pharma, Policy and politics 9/30/16 Devices, Economics, Pharma, Policy and politics 9/30/16

Justifying EpiPen pricing, once again

Read More
Devices, Entrepreneurs, Patients, Pharma, Podcast 9/16/16 Devices, Entrepreneurs, Patients, Pharma, Podcast 9/16/16

MedSentry: Adherence for complex drug regimens (podcast)

Read More
Pharma, Policy and politics 8/26/16 Pharma, Policy and politics 8/26/16

EpiPen may still be too cheap

Read More
Amusements, Culture, Pharma, Uncategorized 7/13/16 Amusements, Culture, Pharma, Uncategorized 7/13/16

Drinking while grocery shopping. Is pot next?

Read More
Culture, Pharma, Policy and politics, Uncategorized 6/15/16 Culture, Pharma, Policy and politics, Uncategorized 6/15/16

Staying away from substance abuse on campus

Read More
Economics, Pharma, Policy and politics, Uncategorized 5/11/16 Economics, Pharma, Policy and politics, Uncategorized 5/11/16

Biosimilars are "me-too" drugs, not generics

Read More
Newer Posts
Older Posts

SERVICES

Growth StrategyDue Diligence for Transactions

SECTORS

Tech-enabled Healthcare Services
Life Sciences

Digital Health and Health IT
Private Equity/Investors

ABOUT

Consultants
Case Studies
History
Testimonials

Media Room
Blog
Contact

101 Federal St., S. 1900 | Boston, MA 02110 | (617) 731-3182

© 2024 Health Business Group. All Rights Reserved.